Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
The Mark Foundation for Cancer Research
AddedFeb 13, 2024
UpdatedJun 28, 2026
The Mark Foundation for Cancer Research

The Mark Foundation for Cancer Research

Operating

NY-based nonprofit, Mark Foundation, accelerates cancer research for improved prevention, diagnosis, and treatment.

Founded
2015
Location
New York City, NY, US
Overview
Compare
Employees
Website

Founded in New York, The Mark Foundation for Cancer Research is a nonprofit organization dedicated to accelerating groundbreaking cancer research. Its core mission is to transform the prevention, diagnosis, and treatment of cancer by funding innovative science across all cancer types. The foundation offers grants to individual investigators and multi-disciplinary teams and invests in early-stage companies. Their programs include proof-of-concept projects, academic drug discovery partnerships, and support for early-career researchers.

The foundation collaborates with leading scientists and institutions to drive impactful research. Notable achievements include significant advancements in cancer treatment methodologies and early detection technologies. By fostering innovation and supporting emerging talent, The Mark Foundation has made substantial contributions to the field of oncology, ultimately aiming to improve patient outcomes and save lives.

The Mark Foundation for Cancer Research - Quick Facts

When was The Mark Foundation for Cancer Research founded?

The Mark Foundation for Cancer Research was founded in 2015.

Where is The Mark Foundation for Cancer Research's headquarters located?

The Mark Foundation for Cancer Research's headquarters is located in New York City, NY, US.

How many employees does The Mark Foundation for Cancer Research have?

The Mark Foundation for Cancer Research has 16 employees as of Feb 4, 2024.

Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
  • Government
  • Non-Profit
Main Product
  • Cancer Research
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621330Offices of Mental Health Practitioners (except Physicians)
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813900Business, Professional, Labor, Political, and Similar Organizations
  • 813920Professional Organizations
  • 810000Other Services (except Public Administration)
SIC
  • 8600Membership Organizations
  • 8690Membership Organizations, Not Elsewhere Classified